Evidence map›Paper›PMID 26485770›Full record

ArticleOncotarget2015

Chromosome transplantation as a novel approach for correcting complex genomic disorders.

Marianna Paulis, Alessandra Castelli, Lucia Susani, Michela Lizier, Irina Lagutina, Maria Luisa Focarelli, Camilla Recordati, Paolo Uva, Francesca Faggioli, Tui Neri and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Chromosome Transplantation: A Possible Approach to Treat Human X-linked Disorders.Molecular therapy. Methods & clinical development · 2020
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Marianna PaulisMilan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
Alessandra CastelliMilan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
Lucia SusaniMilan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
Michela LizierHumanitas Clinical and Research Center, Rozzano, Milan, Italy.
Irina LagutinaAvantea, Cremona, Italy.
Maria Luisa FocarelliMilan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
Camilla RecordatiMouse and Animal Pathology Laboratory, Fondazione Filarete, Milan, Italy.
Paolo UvaCRS4 Bioinformatics Laboratory, Parco Scientifico e Tecnologico POLARIS, Pula, Cagliari, Italy.
Francesca FaggioliMilan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
Tui NeriMilan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
Eugenio ScanzianiMouse and Animal Pathology Laboratory, Fondazione Filarete, Milan, Italy.
Cesare GalliAvantea, Cremona, Italy.
Franco LucchiniCentro Ricerche Biotecnologiche, Università Cattolica del Sacro Cuore, Cremona, Italy.
Anna VillaMilan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
Paolo VezzoniMilan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
Institute of Genetic and Biomedical Research · ITHumanitas University · ITAvantea · ITFondazione Filarete · ITUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic disorders resulting from large rearrangements of the genome remain an important unsolved issue in gene therapy. Chromosome transplantation, defined as the perfect replacement of an endogenous chromosome with a homologous one, has the potential of curing this kind of disorders. Here we report the first successful case of chromosome transplantation by replacement of an endogenous X chromosome carrying a mutation in the Hprt genewith a normal one in mouse embryonic stem cells (ESCs), correcting the genetic defect. The defect was also corrected by replacing the Y chromosome with an X chromosome. Chromosome transplanted clones maintained in vitro and in vivo features of stemness and contributed to chimera formation. Genome integrity was confirmed by cytogenetic and molecular genome analysis. The approach here proposed, with some modifications, might be used to cure various disorders due to other X chromosome aberrations in induced pluripotent stem (iPS) cells derived from affected patients.

Indexed as

X ChromosomeAnimalsEmbryonic Stem CellsGenetic Diseases, InbornGenetic TherapyHypoxanthine PhosphoribosyltransferaseMaleMiceMice, KnockoutMice, NudeMutationHypoxanthine Phosphoribosyltransferasecell therapychromosome transplantationembryonic stem cellsgenomic disordersmicrocell fusion

Identifiers

PMID26485770
PMCPMC4742100
OpenAlexW1933411943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.